2d • General discussion
💉 PT-141 Dosage: What Researchers Should Know
PT-141 (bremelanotide) is a melanocortin receptor agonist that works centrally in the brain—not like Viagra.
FDA-Approved Dosing (HSDD in women):
🔹 1.75 mg subQ
🔹 ~45 min before activity
🔹 Max 1x/24 hrs | Max 8x/month
Research/Off-Label Tiers:
📌 Starting: 0.5 mg once weekly
📌 Maintenance: 1–2 mg once weekly
📌 Max: 2 mg per dose
Dose-Response Data:
- Men: Significant effects at >1.0 mg subQ
- Women: 1.25–1.75 mg showed best response
Common Sides: Nausea (~40%), flushing, headache, BP spikes
Contraindications: Uncontrolled HTN, CVD, pregnancy
0
0 comments
💉 PT-141 Dosage: What Researchers Should Know
powered by
skool.com/biohacking-and-longevity-group-3757
All-in-one peptide education community. 🧪
Dosing guides, storage protocols, stacking frameworks, vendor intel, GLP-1 research, and expert support.🧬
Suggested communities
Powered by